Skip to content

Community and Familial Impacts of the Opioid Crisis

Community and Familial Impacts of the Opioid Crisis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05116852
Enrollment
578
Registered
2021-11-11
Start date
2022-04-01
Completion date
2024-06-21
Last updated
2025-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bereavement, Opioid Use Disorder, Overdose of Opiate

Brief summary

This study aims to analyze the needs of those who have lost a loved one to opioid-related death and/or those currently supporting a loved one in treatment for Opioid Use Disorder. Mental health status related to the death or support of a loved one will be assessed through a survey and through the use of several modules of the CAT-MH (computerized adaptive testing-mental health suite) questionnaire.

Detailed description

This study aims to establish the level of needs in the community among those who have lost loved ones to opioid overdose and/or currently support those in opioid addiction recovery. This study aims to analyze the needs of those who have lost a loved one to opioid-related death and/or those currently supporting a loved one in treatment for Opioid Use Disorder. The study will evaluate the mental health status for each study participant through a primary survey as well as current participant mental health status through the use of several modules of the CAT-MH adaptive testing questionnaire. CAT-MH will be used to rapidly measure severity levels of depression, anxiety, and substance use risk after participants complete the primary survey. The primary survey assesses the immediate impact of overdose death by a loved one and recognition of the onset of opioid addiction in the years after the event on family and community members. The primary survey will compare the impact of loss and/or recovery support on mental health and substance use at specified time points before and after the loss and/or an individual finding out about a loved one's opioid addiction. The primary survey will also evaluate attitudes in this population about mindfulness and self-compassion skills training, openness to technology and various treatment options, current and past levels of depression, anxiety and grief, as well as thematic areas of need specific to those who have lost a loved one to opioid overdose and/or currently support a loved one in opioid addiction recovery.

Interventions

OTHERSurvey

All study participants will be asked to complete two surveys relevant to their personal experience either losing a loved one to opioid-related death, supporting a loved on in recovery for Opioid Use Disorder, or both.

Sponsors

The Sandra and Arnold Gold Humanism Research Fund
CollaboratorUNKNOWN
Cambridge Health Alliance
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 18+, inclusive, who are competent, wish to participate and willing to provide informed consent * Willing and able to participate in completing the surveys using the internet on via smartphone as requested * Identify in one of the 3 groups: (a) Adults who have lost a direct relative or friend to opioid overdose or opioid-related death prior to taking the survey; (2) Adults who are currently supporting a loved one with active opioid addiction; (3) Adults who have lost a direct relative or friend to opioid overdose or opioid related death at least six months prior to survey participation and also currently support a loved one in active addiction recovery.

Exclusion criteria

* Inability to complete the survey * Inability to speak, read, and understand English

Design outcomes

Primary

MeasureTime frameDescription
Establish the percentage of adults who have lost a loved one to opioid overdose who had increased substance use in the year after their loss.Day 1This self-report aim will be assessed via participant survey response asking for recollection of substance use before and after the loss.

Secondary

MeasureTime frameDescription
Compare the level of negative impact on substance use and mental health status in the year after loss due to overdose with the impact on substance use and mental health in the year after becoming aware of a child's opioid addiction.Day 1This aim will be assessed via participant survey response between cohorts
Prolonged GriefDay 1Aa version of the prolonged grief (PG-13) scale will be used to assess presence of prolonged grief after date of loss event.
Establish the percentage of adults who have lost a loved one to opioid overdose who received mental health treatment in the year after their loss.Day 1This self-report aim will be assessed via participant survey response asking for recollection of mental health treatment before and after the loss.

Other

MeasureTime frameDescription
Establish the percentage of adults who have lost a loved one to opioid overdose who had worsening eating disorders, OCD (Obsessive-compulsive disorder), or problematic sexual behaviors in the year after their loss.Day 1This aim will be assessed via participant survey self-report responses.
AnxietyDay 1This aim will be assessed via CAT-MH's CAT-Anxiety adaptive test
PTSD symptomsDay 1This aim will be assessed via CAT-MH's CAT-PTSD adaptive test
Establish the percentage of adults who have lost a loved one to opioid overdose who had worsening depression in the year after their loss.Day 1This self-report aim will be assessed via participant survey response asking for recollection of depression symptoms before and after the loss.
DepressionDay 1This aim will be assessed via CAT-MH's CAT-DI adaptive test (computerized adaptive testing-mental health suite for depression).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026